This article reviews the literature on the use of psychotropic drugs in pregnancy and lactation.
Method:
Medline search yielded more than five hundred titles. Articles were reviewed and ninety-one were selected for reference.
Results:
Fetal physiology and teratogenicity are discussed and the effects of specific drugs on the fetus and newborn are presented. When possible, recommendations for use or non-use are presented.
Conclusions:
Though no controlled studies have ever been done in pregnant women to truly prove their safety, it appears that most, but not all, current psychotropic drugs appear fairly safe for use in pregnancy.
ForfarJ. O. and NelsonM. M.Epidemiology of Drugs Taken by Pregnant Women: Drugs that may Affect the Fetus Adversely, Clinical Pharmacology and Therapeutics, 14: 632–642, 1973.
2.
LewisP., Drug Usage in Pregnancy, in Clinical Pharmacology in Obstetrics, LewisP. (ed.), Wright-PSG, Boston, 1983.
3.
BriggsG.FreemanR. K., and YaffeS. J. (eds.), Drugs in Pregnancy and Lactation—A Reference Guide to Fetal and Neonatal Risk, (3rd Edition), Wilkins and Wilkins, Baltimore, 1990.
4.
ReynoldsF., The Effects on the Infant of Psychotropic Drugs Used in Pregnancy, in Drugs in Pregnancy—Maternal Drug Handling, Fetal Drug Exposure, Academic Press, London, pp. 131–150, 1984.
5.
KernsL. L.Treatment of Mental Disorders in Pregnancy—A Review of Psychotropic Drug Risks and Benefits, The Journal of Nervous and Mental Disorders, 174: 652–659, 1986.
6.
Sitland-MarkenP.RickmanL. A.WellsB. G., and MabieW. C.Management of Acute Mania in Pregnancy, Journal of Clinical Psychopharmacology, 9: 78–87, 1989.
7.
MortolaJ.The Use of Psychotropic Agents in Pregnancy and Lactation, Psychiatric Clinics of North America, 12: 69–87, March 1989.
8.
RiederR. O.RosenthalD., and BlumenthalH.The Offspring of Schizophrenics; Fetal and Neonatal Deaths, Archives of Genera Psychiatry, 32: 200–211, 1975.
9.
CohenL. S.Psychotropic Drug Use in Pregnancy, Hospital and Community Psychiatry, 40: 566–567, June 1989.
10.
GoldbergH. I. and DiMascioA., Psychotropic Drugs in Pregnancy, in Psychopharmacology: A Generation of Progress, Raven Press, New York, pp. 1047–1055, 1978.
11.
RayburnW. F. and AndresenB. D., Principles of Perinatal Pharmacology, in Drug Therapy in Obstetrics and Gynecology, Appleton-Century, Crofts, Norwalk, 1982.
12.
SpielvogelA. and WileJ.Treatment of the Psychotic Pregnant Patient, Psychosomatics, 27: 487–492, July 1986.
13.
SchouM. and AmidsenA.Lithium and Pregnancy III, Report from the Register of Lithium Babies, British Medical Journal, 21: 139, April 1973.
14.
SloneD.SiskindV.HeinonenO. P.Antenatal Exposure to The Phenothiazines in Relation to Congenital Malformations, Perinatal Mortality, Age, Birth Weight, and Intelligence Score, American Journal of Obstetrics and Gynecology, 128: 486–488, 1977.
15.
PlattJ. E.FriedhoffA. J.BromanS. H.Effects of Prenatal Exposure to Neuroleptic Drugs on Childrens Growth, Neuropsychopharmacology, 1: 205–212, 1988.
16.
GolubM. and KornetskyC.Seizure Susceptibility an Avoidance Conditioning in Adult Rats Treated Prenatally With Chlorpromazine, Developmental Psychobiology, 7: 79–88, 1980.
17.
GuzeB. H. and GuzeP. A.Psychotropic Medication Use During Pregnancy, The Western Journal of Medicine, 151: 296–298, September 1989.
18.
Abdul-KarimR. W., Drugs During Pregnancy—Clinical Perspectives, George F. Stickley Company, Philadelphia, pp. 91–101, 1981.
19.
KernsL. L.The Clinical Dilemma of Psychotropic Drug Use During Pregnancy, The Western Journal of Medicine, 151: 321, September 1989.
20.
EdlundM. J.CraigT. J.Antipsychotic Drug Use and Birth Defects: An Epidemiologic Reassessment, Comprehensive Psychiatry, 25: 32–37, 1984.
21.
Rumeau-RouquetteC. and GoujardJ.Possible Teratogenic Effect of Phenothiazines in Human Beings, Teratology, 1: 57–64, February 1977.
22.
HillR. M.DesmondM. M., and KayJ. L.Extrapyramidal Dysfunction in an Infant of a Schizophrenic Mother, Journal of Pediatrics, 69: 589–595, 1966.
23.
LevyW. and WisiewskyK.Chlorpromazine Causing Extrapyramidal Dysfunction, New York State Journal of Medicine, 74: 684–685, 1974.
24.
O'ConnorM.JohnsonG. M., and JamisD. I.Intrauterine Effects of Phenothiazines, Medical Journal of Australia, 1: 416, 1981.
25.
TamnerA.McKeyR.AriasD.Phenothiazine Induced Extrapyramidal Dysfunction in the Neonate, Journal of Pediatrics, 75: 479, 1969.
26.
DesmondM. M.RudolphA. J.HillR. H., Behavior Alterations in Infants Born to Mothers on Psychoactive Medication During Pregnancy, in Congenital Mental Retardation, FarrelG. (ed.), University of Texas Press, Austin, 1967.
27.
Written communication, KrasnerM., Sandoz Pharmaceuticals, 1992.
28.
Indanpaan-HeikkilaJ. and SaxenL., Possible teratogenicity of Imipramine-Chloropyramine, Lancet, pp. 282–284, 1973.
29.
PoulsonE. and RobsonJ. M.Effect of Phenelzine and Some Related Compounds on Pregnancy, Journal of Endocrinology, 30: 205–215, 1964.
30.
Written communication, C. M. Beaseley, Eli Lilly, 1992.
31.
ShaderR. I.Question the Experts, Journal of Clinical Psychopharmacology, 12: 213, 1992.
32.
ShaderR. I.Question the Experts, Journal of Clinical Psychopharmacology, 12: 441, 1993.
33.
Written communication, Pfizer Labs, 1992.
34.
Personal communication, FoltonA., Burroughs-Wellcome Co., 1992.
35.
Written communication, VanDevenderL., Bristol-Myers Squibb, 1992.
36.
Written communication, NolL. P., Ciba-Geigy, 1992.
37.
OstergaardG. Z. and PederssenS. E.Neonatal Effects of Clomipramine Treatment, Pediatrics, 69: 233–234, 1982.
38.
CoweL. and LloydD. J.Neonatal Convulsions Caused by Withdrawal from Maternal Clomipramine, British Medical Journal, 284: 1837–1838, 1982.
39.
SighS.GulatiG.NarangA.Non-narcotic Withdrawal Syndrome in a Neonate Due to Maternal Clomipramine Therapy, Journal of Pediatrics Child Health, 26: 110, 1990.
40.
SchimmellM.KatzE. Z., and ShaagyToxic Neonatal Effects Following Maternal Clomipramine Therapy, Clinical Toxicology, 29: 479–484, 1991.
41.
SchouM.GoldfieldM. D.WeinsteinM. R., and VilleneuveA.Lithium and Pregnancy I, Report from the Register of Lithium Babies, British Medical Journal, 21: 135–136, April 1973.
42.
SchouM.AmidsenA., and SteenstrupO. R.Lithium and Pregnancy II, Report from the Register of Lithium Babies, British Medical Journal, 21: 137–138, April 1973.
43.
JacobsonS. J.JonesK.Prospective Multicentre Study of Pregnancy Outcome after Lithium Exposure during First Trimester, Lancet, 339: 530–533, 1992.
44.
ZalsteinE.KorenG.EinarsonT., and FreedomR. M.A Case Control Study on the Association between First Trimester Exposure to Lithium and Ebstein's Anomaly, The American Journal of Cardiology, 65: 817–818, 1990.
45.
GelenbergA. J., Biological Therapies in Psychiatry Newsletter, 15: 25–26, July 1992.
46.
CohenL. S.RosenbauJ. F., and HellerV. L.Prescribing Lithium for Pregnant Women (letter), American Journal of Psychiatry, 145: 773, 1988.
47.
AngM. S.ThorpJ. A., and ParisiV. M., Maternal Lithium Therapy and Polyhydramnios, Obstetrics and Gynecology, Sep;76(3 Pt 2): 517–519, 1990.
48.
American Medical Association, Drug Evaluation (6th Edition), American Medical Association, Chicago, p. 150, 1986.
49.
SchouM.Lithium Treatment during Pregnancy, Delivery, and Lactation: An Update, Journal of Clinical Psychiatry, 10: 410–413, October 5, 1990.
50.
JonesK. L.LacroR. V.JohnsonK. A.Patterns of Malformations in the Children of Women Treated With Carbamazepine During Pregnancy, New England Journal of Medicine, 320: 1661–1666, 1989.
51.
LindhoutD. and SchmidtyD.In Utero Exposure to Valproate and Neural Defects, Lancet, 1: 329–393, 1986.
52.
Physician's Desk Reference, Medical Economics Co., New Jersey, pp. 512–514, 1992.
53.
KaiS. D.KohmuraH.IshikawaK., Reproductive and Developmental Toxicity Studies of Buspirone Hydrochloride (II)-Oral Administration to Rats During Prenatal and Lactation Periods, Journal of Toxicological Sciences, 15(suppl 1): 61–84, 1990.
54.
SaxenI. and SaxenL.Association Between Maternal Intake of Diazepam and Oral Clefts, Lancet, 2: 498, 1975.
55.
SafraM. J. and OakleyG. P.Association between Cleft Lip With or Without Cleft Palate and Prenatal Exposure to Diazepam, Lancet, 2: 478–480, 1975.
56.
RosenbergL.MitchellA. A.ParsellsJ. L.Lack of Relation of Oral Clefts to Diazepam use During Pregnancy, New England Journal of Medicine, 309: 1282–1285, 1983.
57.
MilkovichL. and Vanden BergB. J.Effects of Prenatal Meprobamate and Chlordiazepoxide Hydrochloride on Human Embryonic and Fetal Development, New England Journal of Medicine, 291: 1268–1271, 1974.
58.
ShionoB. H. and MillsJ. L.Oral Clefts and Diazepam use During Pregnancy (letter), New England Journal of Medicine, 311: 919–920, 1984.
59.
CrombieD. L.PisentR. J.FlemingD. M.Fetal Effects of Tranquilizers in Pregnancy, New England Journal of Medicine, 293: 198–199, 1975.
60.
HeinonenO. P.StoneD., and ShapiroS., Birth Defects and Drugs in Pregnancy, Publishing Sciences Group, Littleton, Massachusetts, 1977.
61.
GeorgeD. T.LadenheimJ. A., and NuttD. J.Effect of Pregnancy on Panic Attacks, American Journal of Psychiatry, 144: 1078–1079, 1987.
62.
Written communication, LobeckF. G., The Upjohn Company, 1992.
63.
HermanJ. B.RosenbaumJ. F., and BrotmanA. W.The Alprazolam to Clonzapam Switch for Treatment of Panic Disorder, Journal of Clinical Psychopharmacology, 7: 175–178, 1987.
64.
CreeJ. E.MyerJ., and HaioleyD. M.Diazepam in Labor: Its Metabolism and Effect on the Clinical Condition and Thermogenesis of the Newborn, British Medical Journal, 4: 251–255, 1973.
65.
McCarthyG. T.O'ConnellB., and RobinsonA. E.Blood Levels of Diazepam in Infants of Two Mothers Given Large Doses of Diazepam During Labor, Journal Obstetrics Gynaecolgic British Commonwealth, 80: 349–352, 1973.
66.
GreenblattD. J. and ShaderR. I., Benzodiazepines in Clinical Practice, Raven Press, New York, pp. 152–158, 1974.
67.
OwenJ. R.Effect of Diazepam Administration to Mothers During Labor on Temperature Regulation of the Neonate, Archives of Disease in Children, 47: 107, 1972.
68.
ScherJ.HaileyD. M., and BeardR. W.The Effects of Diazepam on the Fetus, Journal Obstetrics Gynecology British Commonwealth, 79: 635–638, 1972.
69.
ShannonR. W.FraserG. P., and AitkenR. G.Diazepam in Preeclamptic Toxemia with Special Reference to its Effects on the Newborn Infant, British Journal of Clinical Practice, 26: 271–275, 1972.
70.
SpreightA. N. P.Floppy Infant Syndrome and Maternal Diazepam and/or Nitrazepam, Lancet, 2: 878, 1977.
71.
RementariaJ. L. and BhattK.Withdrawal Symptoms in Neonates from Intrauterine Exposure to Diazepam, Journal of Pediatrics, 90: 123–126, 1977.
72.
MazziE.Possible Neonatal Diazepam Withdrawal: A Case Report, American Journal of Obstetrics and Gynecology, 129: 586–587, 1977.
73.
AthinarayananP.PierogS. H.NigamS. K.Chlordiazepoxide Withdrawal in the Neonate, American Journal of Obstetrics and Gynecology, 124: 212–213, 1976.
74.
BitnumS.Possible Effects of Chlordiazepoxide on the Fetus, Canadian Medical Association Journal, 100: 351, 1969.
75.
SchiffD.ChanG., and SternL.Fixed Drug Combinations and the Displacement of Bilirubin from Albumin, Pediatrics, 8: 139–141, 1971.
76.
KargasG. A.KargasS. A.BruyereH. J.Perinatal Mortality due to Interaction of Diphenhydramine and Temazepam (letter), New England Journal of Medicine, 313: 1417–1418, 1985.
77.
Committee on Drugs, American Academy of Pediatrics, The Transfer of Drugs and Other Chemicals into Human Breast Milk, Pediatrics, 72: 375–383, 1983.
78.
Rivera-CalimilinL.The Significance of Drugs in Breastmilk: Pharmacokinetics Considerations, Clinical Perinatal, 14: 51–70, 1987.
79.
Physician's Desk Reference, Medical Economics Co., New Jersey, p. 944, 1993.
80.
SchouM. and AmidsenA.Lithium and Pregnancy: III. Lithium Ingestion by Children Breastfeed by Women on Lithium Treatment, British Medical Journal, 2: 138, 1973.
81.
SykesP. A.QuarreV., and AlexanderF. W.Lithium Carbonate and Breast Feeding, British Medical Journal, 2: 1299, 1976.
82.
SkausigO. B. and SchouM.Die Giving Under Lithium Behandling, Ugeskrift for Laeger, 139: 400–401, 1977.
83.
TunnessenW. W. and HertzC. G.Toxic Effects of Lithium in Newborn Infants: A Commentary, Journal of Pediatrics, 81: 804–807, 1972.
84.
WoodyJ. N.LondonW. L., and WillbanksG. D.Lithium Toxicity in a Newborn, Pediatrics, 47: 94–96, 1971.
85.
PatrickM. J.TistoneW. J., and ReaveyP.Diazepam and Breastfeeding, Lancet, 1: 542–543, 1973.
86.
StirratG. M.EdingtonP., and BerryD. J.Transplacental Passage of Chlordiazepoxide, British Medical Journal, 43: 729, 1974.
87.
CatzC. S., Drug Therapy, 43: 72–73, 1973.
88.
ErkkolaR. and KantoJ.Diazepam and Breastfeeding, Lancet, 1: 1235–1236, 1972.
89.
AnanthJ.Side Effects in the Neonate from Psychotropic Agents Excreted through Breast-Feeding, American Journal of Psychiatry, 135: 801–804, 1978.
90.
BrandtR.Passage of Diazepam and Desmethyldiazepam into Breast Milk, Arzneimittelforsch, 26: 454–457, 1976.
91.
WarkanyJ.Psychotropic Drugs, Myths and Realities, Advances in Experimental Medicine and Biology, 36: 305–322, 1972.
